This article has been cited by other articles in PMC.
Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (707K), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.
These references are in PubMed. This may not be the complete list of references from this article.
Allison AC, Hovi T, Watts RW, Webster AD. Immunological observations on patients with Lesch-Nyhan syndrome, and on the role of de-novo purine synthesis in lymphocyte transformation. Lancet. 1975 Dec 13;2(7946):1179–1183.[PubMed]
Berlin RD, Oliver JM. Membrane transport of purine and pyrimidine bases and nucleosides in animal cells. Int Rev Cytol. 1975;42:287–336.[PubMed]
Carson DA, Kaye J, Seegmiller JE. Lymphospecific toxicity in adenosine deaminase deficiency and purine nucleoside phosphorylase deficiency: possible role of nucleoside kinase(s). Proc Natl Acad Sci U S A. 1977 Dec;74(12):5677–5681.[PubMed]
Evans WH, Gurd JW. Properties of a 5'-nucleotidase purified from mouse liver plasma membranes. Biochem J. 1973 May;133(1):189–199.[PubMed]
Giblett ER, Ammann AJ, Wara DW, Sandman R, Diamond LK. Nucleoside-phosphorylase deficiency in a child with severely defective T-cell immunity and normal B-cell immunity. Lancet. 1975 May 3;1(7914):1010–1013.[PubMed]
Johnson SM, North ME, Asherson GL, Allsop J, Watts RW, Webster AD. Lymphocyte purine 5'-nucleotidase edficiency in primary hypogammaglobulinaemia. Lancet. 1977 Jan 22;1(8004):168–170.[PubMed]
O'Dorisio MS, Neidhart JA, Daniel FB, Balcerzak SP, LoBuglio AF. Identification of hypoxanthine as the major compoenet of a chromatographic fraction of transfer factor. Cell Immunol. 1976 May;23(2):191–202.[PubMed]
Polmar SH, Stern RC, Schwartz AL, Wetzler EM, Chase PA, Hirschhorn R. Enzyme replacement therapy for adenosine deaminase deficiency and severe combined immunodeficiency. N Engl J Med. 1976 Dec 9;295(24):1337–1343.[PubMed]
Polmar SH. Lymphocyte enzyme deficiencies and the metabolic basis of immunodeficiency disease. Clin Haematol. 1977 Jun;6(2):423–438.[PubMed]
Quagliata F, Faig D, Conklyn M, Silber R. Studies on the lymphocyte 5'-nucleotidase in chronic lymphocytic leukemia, infectious mononucleosis, normal subpopulations, and phytohemagglutinin-stimulated cells. Cancer Res. 1974 Dec;34(12):3197–3202.[PubMed]
Rodan GA, Bourret LA, Cutler LS. Membrane changes during cartilage maturation. Increase in 5'-nucleotidase and decrease in adenosine inhibition of adenylate cyclase. J Cell Biol. 1977 Feb;72(2):493–501.[PMC free article][PubMed]
Shenoy TS, Clifford AJ. Adenine nucleotide metabolism in relation to purine enzymes in liver, erythrocytes and cultured fibroblasts. Biochim Biophys Acta. 1975 Nov 10;411(1):133–143.[PubMed]
Silber R, Conklyn M, Grusky G, Zucker-Franklin D. Human lymphocytes: 5'-nucleotidase-positive and -negative subpopulations. J Clin Invest. 1975 Nov;56(5):1324–1327.[PMC free article][PubMed]
Stoop JW, Zegers BJ, Hendrickx GF, van Heukelom LH, Staal GE, de Bree PK, Wadman SK, Ballieux RE. Purine nucleoside phosphorylase deficiency associated with selective cellular immunodeficiency. N Engl J Med. 1977 Mar 24;296(12):651–655.[PubMed]
Uusitalo RJ, Karnovsky MJ. Surface localization of 5'-nucleotidase on the mouse lymphocyte. J Histochem Cytochem. 1977 Feb;25(2):87–96.[PubMed]
Webster AD, North M, Allsop J, Asherson GL, Watts RW. Purine metabolism in lymphocytes from patients with primary hypogammaglobulinaemia. Clin Exp Immunol. 1978 Mar;31(3):456–463.[PubMed]
Articles from Journal of the Royal Society of Medicine are provided here courtesy of Royal Society of Medicine Press